EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Multimodal Approach for Recalcitrant Melasma Using Picosecond Laser and Topical JAK Inhibition: A Case Report

Hasan Ashkanani iD, Maryam AlZaabi, Abdulaziz AlRasheed, Wael AlDaraji

Journal of Cosmetic Dermatology · 2026-04 · 25 (4)

DOI: 10.1111/jocd.70783 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 25.03.2026. Verfasst von Hasan Ashkanani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Al-Amiri Hospital, Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Melanosis, Lasers, Solid-State, Janus Kinase Inhibitors, Low-Level Light Therapy. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melasma is a chronic hyperpigmentation disorder with high relapse rates, particularly in Fitzpatrick skin types III–V. Increasing evidence implicates cytokine‐driven inflammation and visible light–induced melanogenesis as key contributors to disease persistence. These mechanisms support the rationale for exploring a multimodal therapeutic approach. Case Presentation A woman in her early 30s with phototype IV presented with a 5‐year history of recalcitrant centrofacial melasma. Previous treatments—including hydroquinone, oral tranexamic acid, and superficial chemical peels—produced only transient and incomplete improvement. Baseline Melasma Severity Index (MSI) score was 7.9, consistent with moderate‐to‐severe disease.

Intervention

Treatment consisted of low‐fluence picosecond 755 nm alexandrite laser, short‐term topical corticosteroid post‐procedure, initiation of topical tofacitinib 2% cream twice daily for 11 months, and continuous iron oxide–based visible light–blocking photoprotection. Laboratory monitoring during therapy remained normal. Outcome At 11 months, the patient achieved near‐total clearance with an MSI reduction from 7.9 to 0.10 (98.7% improvement). No adverse events, post‐inflammatory hyperpigmentation, or relapse were observed, including 3 months after treatment cessation.

Conclusion

This case illustrates the potential clinical value of combining pigment‐targeted picosecond laser therapy with topical JAK inhibition and visible light–specific photoprotection for recalcitrant melasma. The durable remission achieved supports further investigation into anti‐inflammatory and photoreactive pathway modulation as adjunctive strategies in melasma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanosisLasers, Solid-StateJanus Kinase InhibitorsLow-Level Light TherapyPyrimidinesPiperidinesHumansFemaleCombined Modality TherapyAdultTreatment OutcomeSeverity of Illness IndexAdministration, Cutaneous

Stichwörter der Autor:innen

LASERMelasmahyper‐pigmentation

Substanzen

Janus Kinase InhibitorsPyrimidinesPiperidines

Autor:innen und Institutionen

  • Department of Dermatology, Al-Amiri Hospital, Kuwait City, Kuwait.
  • Department of Dermatology, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait.
  • Department of Plastic Surgery, Kuwait Hospital, Sabah AlSalem, Kuwait.
  • Dr. Gera Tagani Research Centre, Newcastle University, London, UK.

ORCID-Profile: Hasan Ashkanani

Zitieren

APA

Ashkanani, H., AlZaabi, M., AlRasheed, A., & AlDaraji, W. (2026). Multimodal Approach for Recalcitrant Melasma Using Picosecond Laser and Topical JAK Inhibition: A Case Report. Journal of Cosmetic Dermatology, 25(4). https://doi.org/10.1111/jocd.70783

Vancouver

Ashkanani H, AlZaabi M, AlRasheed A, AlDaraji W. Multimodal Approach for Recalcitrant Melasma Using Picosecond Laser and Topical JAK Inhibition: A Case Report. Journal of Cosmetic Dermatology. 2026;25(4). doi:10.1111/jocd.70783

BibTeX
@article{Ashkanani2026,
  author = {Ashkanani, Hasan and AlZaabi, Maryam and AlRasheed, Abdulaziz and AlDaraji, Wael},
  title = {Multimodal Approach for Recalcitrant Melasma Using Picosecond Laser and Topical JAK Inhibition: A Case Report},
  journal = {Journal of Cosmetic Dermatology},
  year = {2026},
  volume = {25},
  number = {4},
  doi = {10.1111/jocd.70783}
}
Kostenlos starten →